NCT04783428View on ClinicalTrials.gov

Tumor-induced Osteomalacia Disease Monitoring Program

Active, not recruitingOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

February 28, 2032

Study Completion Date

February 28, 2032

Conditions
Tumor-induced Osteomalacia (TIO)
Interventions
OTHER

No intervention

Access to any treatment is through authorized commercial use and not as part of this DMP

Trial Locations (6)

21218

Johns Hopkins University, Baltimore

22908

University of Virginia, Charlottesville

37235

Vanderbilt University Medical Center, Nashville

47405

Indiana University, Bloomington

06520

Yale University, New Haven

Unknown

IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires

All Listed Sponsors
lead

Ultragenyx Pharmaceutical Inc

INDUSTRY